Figure 1From: Antiretroviral tolerability and efficacy after switch to saquinavir in PI-experienced patients: 48-week analysis of the German Rainbow CohortMedian changes in triglycerides (LOCF) from baseline to week 48 – stratified according to baseline level – after start of an SQV/r containing antiretroviral therapy in PI-pretreated, but SQV-naïve patients.Back to article page